← FDA Drug Approvals (Drugs@FDA)

BREXPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN PHARMS INC · Approved 2023-01-25

Drug application

FDA Application #

ANDA213740

Application type

Abbreviated New Drug Application (Generic)

Brand name

BREXPIPRAZOLE

Generic name

Brexpiprazole

Active ingredients

BREXPIPRAZOLE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

MSN PHARMS INC

First approval

2023-01-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown